Sanara MedTech Inc. Announces Strategic Realignment to Focus on Surgical Business

(NASDAQ:SMTI), Completes Evaluation of Strategic Alternatives for Tissue Health Plus Segment FORT WORTH, TX, Nov. 11, 2025 (GLOBE NEWSWIRE) — Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market, […]

Alico, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on Monday, November 24, 2025

(NASDAQ:ALCO), FORT MYERS, Fla., Nov. 11, 2025 (GLOBE NEWSWIRE) — Alico, Inc. (“Alico” or the “Company”) (Nasdaq: ALCO) today announced that the Company will release financial results for the fourth quarter and full year ended September 30, 2025, on Monday, November 24, 2025 after market close. The Company will host a conference call to discuss

MannKind to Present at the Jefferies Global Healthcare Conference

(NasdaqGM:MNKD), DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD) announced today that Michael Castagna, Chief Executive Officer, and Chris Prentiss, Chief Financial Officer, are scheduled to present and share updates during the Jefferies London Healthcare Conference on Wednesday, November 19, at 6:30 am ET/11:30 am GMT. The

Iridex Reports Third Quarter 2025 Financial Results

(NasdaqGM:IRIX), MOUNTAIN VIEW, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) — Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial results for the third quarter ended September 27, 2025. Third Quarter 2025 Financial Highlights Generated

Lifecore Biomedical to Participate in Upcoming Investor Conferences

(NASDAQ:LFCR), CHASKA, Minn, Nov. 11, 2025 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in two upcoming investor conferences. Details regarding Lifecore's participation are as follows: Jefferies 2025 Global Healthcare Conference – London Details: Paul Josephs, Lifecore's president

Proficient Auto Logistics Reports Third Quarter 2025 Financial Results

Proficient Auto Logistics Reports Third Quarter 2025 Financial Results GlobeNewswire November 11, 2025 JACKSONVILLE, Fla., Nov. 11, 2025 (GLOBE NEWSWIRE) — Proficient Auto Logistics, Inc. (NASDAQ: PAL) (the “Company” or “Proficient”) today reported its financial results for the three months ended September 30, 2025. Third Quarter Summary Total Operating Revenue of $114.3 million, increased 24.9%

Los Angeles Influence Announces Investigation Into the LuxUrban Story – The $300 Million Hotel Startup That Paid Workers 115% of Their Wages While the City Never Paid Up

Los Angeles Influence Announces Investigation Into the LuxUrban Story – The $300 Million Hotel Startup That Paid Workers 115% of Their Wages While the City Never Paid Up GlobeNewswire November 11, 2025 Los Angeles, CA, Nov. 11, 2025 (GLOBE NEWSWIRE) — Los Angeles Influence is proud to spotlight a powerful investigative feature from Legal Tech

Black Rock Coffee Bar, Inc. Reports Third Quarter 2025 Results

Black Rock Coffee Bar, Inc. Reports Third Quarter 2025 Results GlobeNewswire November 11, 2025 Total Revenue Growth of 24.2% Year Over Year Same Store Sales Growth of 10.8% Year Over Year Opened 11 New Stores in the Third Quarter SCOTTSDALE, Ariz., Nov. 11, 2025 (GLOBE NEWSWIRE) — Black Rock Coffee Bar, Inc. (Nasdaq: BRCB) (“Black

Turn Therapeutics CEO, Bradley Burnam, Speaks with Former Director of the Centers for Disease Control and Prevention Dr. Robert Redfield, M.D.

Turn Therapeutics CEO, Bradley Burnam, Speaks with Former Director of the Centers for Disease Control and Prevention Dr. Robert Redfield, M.D. Conversation Centered Around Healthcare Communications and Pandemic Preparedness GlobeNewswire November 11, 2025 LOS ANGELES, Nov. 11, 2025 (GLOBE NEWSWIRE) — Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing dermatologic, advanced wound, and

ANI Pharmaceuticals to Present at the Jefferies Global Healthcare Conference – London

ANI Pharmaceuticals to Present at the Jefferies Global Healthcare Conference – London GlobeNewswire November 11, 2025 PRINCETON, N.J., Nov. 11, 2025 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference – London

Scroll to Top